SCHEMBL24695808

SCHEMBL24695808

CCc1cc(C2CCCCC2)nc2cc(C(=O)O)nn12

nearest known ligand 0.45

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ KMO O15229 1/20 0.44
▸ KDM4E B2RXH2 6/20 0.43
▸ ALDH1A1 P00352 4/20 0.43
▸ HPGD P15428 5/20 0.41
▸ GAA P10253 1/20 0.41
▸ KMT2A Q03164 2/20 0.41
▸ HTT P42858 3/20 0.40
▸ HSD17B10 Q99714 2/20 0.40
▸ POLB P06746 1/20 0.40
▸ BLM P54132 1/20 0.40
▸ LMNA P02545 2/20 0.40
▸ NPSR1 Q6W5P4 2/20 0.40
▸ MAPK1 P28482 1/20 0.40
▸ L3MBTL1 Q9Y468 1/20 0.40
▸ SMN1; SMN2 Q16637 1/20 0.39
▸ MEN1 O00255 1/20 0.38
▸ CASP1 P29466 1/20 0.38
▸ ESR2 Q92731 1/20 0.38
▸ PTGER1 P34995 1/20 0.37
▸ TDP1 Q9NUW8 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL24695635 1.00 KMO (0.44) KMOKDM4EALDH1A1HPGDGAA
SCHEMBL20064749 0.86 KMO (0.43) KMOKDM4EALDH1A1HPGDGAA
SCHEMBL24696226 0.86 HPGD (0.59) KDM4EALDH1A1HPGDGAAKMT2A
SCHEMBL24695637 0.86 HPGD (0.42) KDM4EALDH1A1HPGDGAAKMT2A
SCHEMBL24695810 0.86 HPGD (0.42) KDM4EALDH1A1HPGDGAAKMT2A
SCHEMBL24696384 0.82 P2RY14 (0.37) KDM4EALDH1A1HPGDGAAKMT2A
SCHEMBL24696143 0.82 P2RY14 (0.37) KDM4EALDH1A1HPGDGAAKMT2A
SCHEMBL24695982 0.81 HPGD (0.48) KMOKDM4EALDH1A1HPGDGAA
SCHEMBL24696341 0.81 KDM4E (0.37) KDM4EALDH1A1HPGDGAAKMT2A
SCHEMBL24696319 0.80 HPGD (0.52) KMOKDM4EALDH1A1HPGDGAA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2022255408-A1 PYRAZOLO[1,5-A]PYRIMIDINE COMPOUND FOR THE TREATMENT OF DERMAL DISORDERS OTSUKA PHARMACEUTICAL CO., LTD. (JP) 2022-12-08 — — WO disclosed
Send feedback